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Objectives. STRO-1 positive periodontal ligament cells (PDLCs) and unsorted PDLCs have demonstrated potential for periodontal
regeneration, but the comparison between unsorted cells and the expanded STRO-1 sorted cells has never been reported.
Additionally, Wnt3a is involved in cell proliferation thus may benefit in vitro PDLC expansion. The aim was to evaluate the effect
of STRO-1 cell sorting andWnt3a treatment on cell behavior of human PDLCs (hPDLCs).Materials and Methods. STRO-1 positive
hPDLCs were sorted and the sorted cells were expanded and compared with their unsorted parental cells. Thereafter, hPDLCs
were treated with or without Wnt3a and the cell proliferation, self-renewal, and osteogenic differentiation were evaluated. Results.
No differences were measured between the expanded STRO-1-sorted cells and unsorted parental cells in terms of proliferation,
CFU, and mineralization capacity. Wnt3a enhanced the proliferation and self-renewal ability of hPDLCs significantly as displayed
by higher DNA content values, a shorter cell population doubling time, and higher expression of the self-renewal gene Oct4.
Moreover, Wnt3a promoted the expansion of hPDLCs for 5 passages without affecting cell proliferation, CFU, and osteogenic
capacity. Conclusions. Expanded STRO-1-sorted hPDLCs showed no superiority compared to their unsorted parental cells. On the
other hand, Wnt3a promotes the efficient hPDLC expansion and retains the self-renewal and osteogenic differentiation capacity.
1. Introduction
Periodontitis is a multifactorial disease caused primarily by
dental plaque microorganisms [1]. Periodontitis is charac-
terized by the destruction of the periodontium, including
gingiva, periodontal ligament (PDL), cementum, and alveolar
bone. Without adequate treatment, periodontitis will finally
lead to tooth loss, which often affects nutrition intake and
self-confidence. Approximately 48% of adults have chronic
periodontitis and advanced periodontitis is more prevalent
among the older age groups [1, 2]. Current treatments are
generally successful in preventing active disease, but the
regeneration of the lost tissues remains a challenge. Recently,
substantial progress has been made in periodontal tissue
regeneration by cytotherapeutic approaches to overcome the
limitations of existing procedures [3–5].
Several cell types have been used for periodontal regen-
eration including periodontal ligament cells (PDLCs), bone
marrow stromal cells (BMSCs), alveolar periosteal cells
(APCs), dental follicle cells (DFCs), and dental pulp cells
(DPCs) [3, 5–7]. Tsumanuma et al. transplanted PDLCs,
BMSCs, and APCs in canine one-wall intrabony defects for
eight weeks [6] and results showed that significantly more
newly formed cementum and well-oriented PDL fibers were
formed in the PDLCs group than in the other groups. Besides,
in an organ culture study performed on tooth root surfaces,
new alveolar bone and PDL-like tissues were formed only by
PDLCs but not by DFCs, DPCs, or BMSCs [7]. These results
indicate that PDLCs may be the most suitable cell source for
periodontal tissue regeneration.
STRO-1, one of themost well-knownmesenchymal stem-
cell markers, has gained increasing interest in stem cell
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sorting over the past decade [7–11]. For instance, STRO-1
has been utilized for the selection of PDL stem cells [8],
dental pulp stem cells [7, 9], and adipose-derived stem cells
[10]. STRO-1 positive PDL stem cells are usually utilized for
research purpose and their potential to regenerate periodon-
tal tissues in vivo has been reported [8]. Since PDLCs contain
subpopulations of stem cells [12], the heterogeneous unsorted
PDLCs have also been shown to promote periodontal tissue
formation [5, 7, 9, 10]. The sorted stem cells in high purity
might provide a better cell source for therapeutic purposes
compared with the heterogeneous unsorted cells. But STRO-
1 positive cells are usually found in low numbers [13, 14] and
therefore in vitro expansion is needed. However, the expres-
sion of STRO-1 was gradually lost during culture expansion,
as suggested in previous studies [13, 14]. Yet, the comparison
between unsorted parental cells and the expanded STRO-1
sorted cells (equal expansion as the parental cells) has never
been reported. Moreover, from a practical point of view, the
cell selection and expansion procedure are time-consuming.
Thus, it is of importance to compare unsorted parental cells
and the expanded STRO-1 sorted cells from PDLCs in order
to benefit their future clinical applications.
Along with the high quality, large quantity of cells is
necessary for effective therapeutic applications. For instance,
160 million cells would be required for 20 cubic centimeter
of tissue engineered bone implant based on using 8 million
cells/cm3 scaffold [15, 16] to gain substantial bone formation.
PDLCs are easily accessible but the cell number is very
limited from primary cell culture, and hence it requires in
vitro expansion before clinical applications. Yet characteristic
changes of PDLCs have been observed during passaging
[13]. Alkaline phosphatase (ALP) activity of PDLCs gradually
decreased as the passage number increased [13].Thus, finding
a method that can benefit the efficient in vitro expansion of
PDLCs is required.
The cellular signaling pathways that control the pro-
liferation of PDLCs are unclear. A promising candidate is
the Wnt signaling, which is involved in tooth development
[17, 18]. Wnt signaling affects tooth size [17] and induces
continuous tooth generation in mouse [18]. As reported
in a previous study [19], in a continuously erupting tooth,
cells with the highest level of Wnt responsiveness also show
the highest proliferation. Wnt3a, a representative canonical
Wnt member, has been recently isolated as an active Wnt
molecule [20]. Wnt3a can enhance clonal outgrowth of
neural stem cells [21] and promote long-term expansion of
mammary stem cells [22]. Furthermore, Wnt signaling has
been suggested to play an essential role in osteogenesis in
vitro and in vivo [23–25]. For example, Wnt3a suppressed
osteogenic differentiation of mesenchymal stem cells (MSCs)
[23]. However, whether Wnt3a can directly control the
proliferation and differentiation of adult human PDLCs is not
known.
The aim of this study was to evaluate the effect of STRO-1
cell sorting and Wnt3a treatment on cell behavior of human
PDLCs (hPDLCs). To this end, STRO-1 positive PDLCs were
sorted and then the sorted cells were expanded and compared
with their unsorted parental cells in terms of proliferation,
colony forming unit (CFU), and mineralization. Thereafter,
hPDLCs were treated with or withoutWnt3a and the cell pro-
liferation, self-renewal, and osteogenic differentiation were
evaluated. It was hypothesized that Wnt3a can benefit the
efficient in vitro expansion of hPDLCs by enhancing cell
proliferation and self-renewal, while inhibiting osteogenic
differentiation.
2. Materials and Methods
2.1. Cell Isolation. All experiments were done by follow-
ing national guidelines for working with human materials
(Dutch federation of biomedical scientific societies. Human
tissue and medical research: code of conduct for responsible
use, available at: http://www.federa.org/). After patients had
signed informed consent, adult hPDLCs from 3 patients
(20, 24, and 33 years old, resp.) were obtained from healthy
impacted third molars, which were routinely extracted for
the prevention of third molar-related morbidity. The PDL
was scraped from the middle third of the roots, dissected,
and placed in a 25 cm2 culture flask in proliferation medium,
which contained 𝛼-MEM (Gibco) supplemented with 10%
FCS (Gibco) and 100 units/mL pen/strep (Gibco). Bone was
harvested from the posterior maxilla of 1 patient (41 years
old) during dental implant surgery. Bone debris was retrieved
from the drill surface and chopped into small pieces and put
into a 50mL tube. The tube with minced bone debris and
proliferation medium was shaken vigorously and medium
with human bone marrow stromal cells (hBMSCs) was
collected and plated in a 25 cm2 culture flask. Upon 70–80%
confluency, hPDLCs and hBMSCs were subcultured for 3
passages and afterwards cryopreserved in𝛼-MEMcontaining
20% FCS and 10% DMSO (Sigma).
2.2. Cell Characterization. After defrosting, the morphology
of hPDLCs was observed by an inverse phase contrast
microscope (Leica DMIL, Germany) at ×10 magnification.
The self-renewal and osteogenic ability of hPDLCs from
the 4th passage were characterized by colony-forming unit
(CFU) efficiency, ALP activity, and mineralization ability
(Von-Kossa staining). CFU assay was performed on day
10 in proliferation medium. ALP activity of hPDLCs was
measured on day 8 in osteogenic medium (proliferation
medium containing 50 𝜇g/mL ascorbic acid, 10mM sodium
𝛽-glycerophosphate, and 10 nM dexamethason, all from
Sigma). Human fibroblasts from foreskin (a kind gift from
Department of Orthodontics and Oral Biology, Radboud
University Medical Centre) and hBMSCs were used as neg-
ative and positive control for ALP activity assay. Von-Kossa
staining was performed after 30 days of culture in osteogenic
medium. All the assays are described in detail below.
2.3. STRO-1 Fluorescence-Activated Cell Sorting and Testing.
The cryopreserved hPDLCs from 2 donors were defrosted
and performed for cell sorting experiments. Single hPDLC
suspensions containing 10 × 106 cells from the 4th passage
were obtained through a 70 𝜇m cell strainer (Falcon BD,
Franklin lakes, NJ, USA). Next, the cell suspensions were cen-
trifuged at 400 g for 10min, resuspended in 1mLPBS/1%BSA,
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and preincubated for 20min on ice. Subsequently, cells
were incubated with 200 𝜇L mouse anti-human monoclonal
STRO-1 IgM primary antibody (2.5 𝜇g/106 cells, R&D Sys-
tems, Minneapolis, MN) in PBS/1%BSA for 15min on ice
and washed 3 times with PBS followed by centrifugation at
250 g for 5minutes.The cell pellet was resuspended in 200𝜇L
PBS/1%BSAwith 10 𝜇L phycoerythrin- (PE-) conjugated goat
anti-mouse IgM antibody (R&D Systems, Minneapolis, MN)
for 30min on ice, washed for 3 times, resolved in 400𝜇L of
PBS, and kept on ice until sorting. For blank control, PBS
was substituted for the primary and second antibodies. To
confirm the specificity of primary antibody binding, nonspe-
cificmouse IgM isotype control (lambdamonoclonal, abcam)
which ideally matches the primary antibody’s host species
was substituted for the primary antibody. All incubations
were performed in the dark at 4∘C. Cells were sorted using
a FACStar Plus flow cytometer (Beckton Dickinson & Co.,
Mountain View, CA). Positivity was defined as a level of
fluorescence greater than 99% of the blank (without 1st and
2nd antibodies) and negative (without 1st antibody) control.
To prove the efficacy of the applied FACS sorting, sorted
cells and controls (STRO-1+/STRO-1−/un-sorted cells) were
evaluated by fluorescence microscopy and flow cytometry.
STRO-1+ cells were collected and expanded to 10 × 106cells
in proliferation medium. The expanded cells were compared
with their unsorted parental cells in terms of proliferation
(DNA content on days 2, 4, and 6 in proliferation medium),
CFU ability (day 10 in proliferation medium), and miner-
alization capacity (calcium content on day 30 in osteogenic
medium). All the assays are described in detail below.
2.4. Direct Effect of Wnt3a on hPDLCs. Based on the STRO-
1 cell sorting results, unsorted hPDLCs at 4th passage were
used in this study. hPDLCs from 3 donors were treated with
or without 50 ng/mLWnt3a (R&D Systems). The dosage was
chosen according to a previous study in which 50 ng/mL
Wnt3a promoted long-term expansion of mammary stem
cells [22]. Then, DNA content, gene expression (self-renewal
gene markers Oct4, Nanog and Sox2, and osteogenic gene
markers ALP, Runx-2, and OC), ALP activity, and calcium
content were evaluated. All the assays are described in detail
below.
2.5. Functionality of PDLCs Pretreated with Wnt3a. For a
long-term study, hPDLCs from passage 4 were subcultured
with or without 50 ng/mL Wnt3a up to passage 9, and at
each passage the cell doubling time was calculated. After
pretreatment with or without Wnt3a for 5 passages, the func-
tionality ofWnt3a-pretreated and control cells was compared
in terms of proliferation (DNA content), CFU, and osteogenic
differentiation (ALP activity and calcium content). All the
assays are described in detail below.
2.6. DNA Assay. After 2, 4, and 6 days of incubation in
proliferationmedium, samples were prepared by washing the
cells layers twice with PBS and adding 1mL of MilliQ to
each well, after which repetitive freezing (−80∘C) and thaw-
ing (37∘C) cycles were performed. DNA analysis was per-
formed via a PicoGreen dsDNA quantification kit (Molecular
Probes, Leiden, The Netherlands) following manufacturer’s
instructions. Briefly, 100 𝜇L of DNA standard or sample was
incubated with 100𝜇L of working solution for 10min at RT
in the dark. After incubation, DNA content was measured
using a fluorescence microplate reader (Bio-Tek Instruments,
Abcoude, The Netherlands) with excitation filter 485 nm and
emission filter 530 nm.
2.7. ALPActivity. Cells in osteogenicmediumwere harvested
at days 7 and 10 in the same way as cells for the DNA content.
Then, 100 𝜇L of substrate solution (p-nitrophenyl phosphate)
was added to 20𝜇L of buffer (0.5M 2-amino-2-methyl-1-
propanol) and 80𝜇L of sample or standard in a 96-well plate.
The standards were made by serial dilutions of 4-nitrophenol
at final concentrations of 0–25 nM.The plate was incubated at
37∘C for 1 hour.The reactionwas terminated by adding 100𝜇L
of 0.3MNaOH.The absorbance of each well wasmeasured in
an ELISA microplate reader (Bio-Tek Instruments, Abcoude,
The Netherlands) at 405 nm. ALP activity was normalized to
the amount of DNA.
2.8. Calcium Content. After 30 days of culture in osteogenic
medium, cells were washed twice with PBS and then 1mL
of 0.5N acetic acid was added to the each well. The tissue
culture plate was incubated overnight on a shaking table.The
calcium content was measured by the ortho-cresolphthalein
complexone (OCPC) method (Sigma). For the biochemical
assay, 10 𝜇L samples or standards were incubated with 300 𝜇L
of working solution (GenzymeDiagnostics, Cambridge, MA,
USA) in a 96-well plate. Standards (0–100 𝜇g/mL) were
generated using a CaCl
2
stock solution. The plate was incu-
bated at RT for 10min and then the absorbance of each
well was measured in the ELISA microplate reader (Bio-Tek
Instruments, Abcoude, The Netherlands) at 570 nm.
2.9. Von Kossa Staining. After 30 days of osteogenic induc-
tion, cells were fixed in 10% formalin for 20min, rinsed
with MilliQ, and then stained with 5% silver nitrate (AgNO
3
,
Merck) for 30min. After washing with distilled water, the
staining was developed with 5% sodium carbonate (Na
2
CO
3
,
Merck), fixedwith 5% sodium thiosulphate (Na
2
S
2
O
3
,Merk),
and examined by using a stereomicroscope (Leica MZ12,
Germany).
2.10. CFU Assay. Single cell suspensions (1000 cells/mL;
100 𝜇L) were seeded into one well of a 6-well plate in
proliferation medium. After 10 days, the samples were fixated
with 10% formalin and stained with 0.1% toluidine blue
(Sigma, Chemical Co., St. Louis, MO, USA). Colony-forming
efficiency (an aggregate of ≥50 cells was scored as a colony)
was determined by the number of colonies relative to the
total number of seeded cells in each plate using a microscope
(Leica DMIL, Germany).
2.11. Real-Time PCR. Cells in proliferation medium at day 5
(Oct4, Nanog, and Sox2 gene expression) and in osteogenic
medium at days 7 and 14 (ALP, Runx-2, and OC gene
expression) were washed twice with PBS. Total RNA was
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extracted using TRIzol reagent (Invitrogen, Breda, The
Netherlands) following manufacturer’s instructions. RNA
concentrations and purity were determined by NanoDrop
(ND-2000, Thermo Scientific). Then, the reverse transcrip-
tase (RT) reaction of 1 𝜇g RNA for each sample was per-
formed using the Superscript III First-strand Synthesis Sys-
tem (Invitrogen, Breda, the Netherlands) for RT-PCR. The
cDNA was amplified and gene expression was quantified
with real-time PCR (BIORAD, CFX96 real-time system).The
primers used were Oct4, Nanog, Sox2, ALP, Runx-2, and OC
(sequences in Table 1). The expression levels were analyzed
versus the housekeeping gene GAPDH. The specificity of the
primers was tested before the real-time PCR reaction. IQ
SYBR Green Supermix PCR kit (BioRad, Hemel Hempstead,
United Kingdom) was used for real-time measurement. The
melting temperature (Tm) employed for each primer pair was
60∘C. The gene expression was calculated using the 2−ΔΔCt
method and the control was used as the calibrator group.
2.12. Statistical Analysis. Each assay was performed in trip-
licate for each donor and statistical analysis was performed
using GraphPad InStat (GraphPad Software, San Diego Cal-
ifornia USA). Results were statistically evaluated for each
donor using an unpaired t-test (significance level, P < 0.05).
3. Results
As all the donors showed the similar trend, only the result
from one donor was presented below unless specifically
mentioned.
3.1. Characterization of hPDLCs. hPDLCswere characterized
on basis of their morphology, self-renewal, and osteogenic
ability. Microscopy observation revealed spindle-shape cell
morphology. hPDLCs displayed the ability to form colonies
when cultured in proliferation medium after 10 days. ALP
activity was confirmed in the hPDLC culture after 8 days
in osteogenic medium. The ALP activity in hPDLCs was in
between hBMSCs (positive control) and fibroblasts (nega-
tive control) cultured at the same conditions (Figure 1(a)).
hPDLCs inducedmineralization as determined by VonKossa
staining after 30 days of osteogenic induction (Figure 1(b)).
3.2. Comparison between Expanded STRO-1-Sorted Cells and
Unsorted Parental Cells. The efficiency of FACS sorting was
proved by fluorescent microscopy observation and flow
cytometry. The STRO-1+ cells were expanded for 4 passages
to achieve 10 × 106 cells, the same number as their unsorted
parental cells. During this expansion, the percentage of
STRO-1+ cells decreased significantly from 95.3% to 2.3%
(Figure 2(a)). Additionally, after 4 passages of in vitro expan-
sion, no significant difference was observed between the
expanded STRO-1-sorted cells and unsorted parental cells in
terms of DNA content, CFU number, and calcium content
(Figures 2(b)–2(d)).
3.3. The Direct Effect of Wnt3a on hPDLCs. The effect of
Wnt3a on hPDLC proliferation was assessed by measuring
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Figure 1: Characterization of hPDLCs. (a) ALP activity of the
hPDLCswas lower compared to hBMSCs (positive control) on day 8,
while fibroblasts were negative. (b) Mineral deposition was detected
by a Von Kossa staining (black color) after 30 days of osteogenic
induction. Error bars represent standard deviation.
cell DNA content and calculating cell doubling time during
passaging.Wnt3a treated cells exhibited a significant increase
(P < 0.05; around 50% increase for day 4 and day 6 in
DNA content compared to the nontreated control group;
Figure 3(a)). In addition, Wnt3a-treated cells displayed sig-
nificantly shorter population doubling time when compared
to untreated control cells, which were 25.46 ± 3.76 versus
30.73 ± 0.9 hours (P < 0.05).
The self-renewal abilitywas evaluated by the expression of
the self-renewal genes octamer-binding transcription factor
4 (Oct4), Nanog, and sex determining region Y-box 2 (Sox2).
The mRNA expression of Oct4 was significantly higher (P <
0.05) for the cells treated with Wnt3a than for the control
cells (Figure 3(b)). Wnt3a-treated cells also exhibited higher
Nanog and Sox2 expression, but a significant difference was
only observed in one donor.
Osteogenic differentiation was assessed by gene expres-
sion of ALP, runt-related transcription factor 2 (Runx-2),
and osteocalcin (OC), ALP activity, calcium content in the
extracellular matrix, and Von Kossa staining. PCR revealed
significantly lower (P < 0.05) ALP gene expression for
Wnt3a-treated cells at day 7 compared to the control group
(Figure 4(a)). For the Runx-2 and OC gene expression no
significant difference was found at day 7 and day 14 between
theWnt3a-treated and control groups (Figures 4(a) and 4(b)).
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Table 1: Primer sequences used for real-time qPCR.
Forward (5󸀠 → 3󸀠) Reverse (5󸀠 → 3󸀠)
Oct4 TTGCCCTTCTGGCGCCGGTTA GTCAGGCCCGTCTCAGCTCATTG
Nanog TTGTCCCCAAAGCTTGCCTTGCT TTCTTACCAGTCTCCGTGTGAGGC
Sox2 AAAAACAGCCCGGACCGCGT TCGTCGATGAACGGCCGCTT
ALP GGGACTGGTACTCGGATAACGA CTGATATGCGATGTCCTTGCA
Runx-2 GAGCACAAACATGGCTGAGA TGGAGATGTTGCTCTGTTCG
OC AGGGCAGCGAGGTAGTGAAGA TAGACCGGGCCGTAGAAGC
GAPDH CGATGCTGGCGCTGAGTAC CGTTCAGCTCAGGGATGACC
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Figure 2: Representative results of STRO-1 cell sorting. (a) The percentage of sorted STRO-1+ cells decreased to 2.3% after 4 passages of in
vitro expansion. (b) No difference in proliferationwas observed between the expanded STRO-1-sorted cells and the unsorted parental cells. (c)
Expanded STRO-1-sorted cells displayed no difference compared to the unsorted parental cells in colony forming number. (d) No difference
in calcium content was observed between expanded STRO-1-sorted cells and parental hPDLCs. Error bars represent standard deviation.
ALP activity at days 7 and 10 demonstrated significantly lower
(P < 0.05) levels forWnt3a-treated cells versus untreated cells
(Figure 4(c)). The long-term mineralization was evaluated
by calcium content deposited by the cells and a Von Kossa
staining after 30 days of culture. Both Wnt3a treated and
untreated cells induced mineralization as determined by
Von Kossa staining and no significant difference in calcium
content was observed between the two groups (Figure 4(d)).
3.4. Functionality ofWnt3a Pretreated hPDLCs. After passage
9, Wnt3a was no longer added to the culture medium and the
proliferation, CFU, and osteogenic differentiation capacity
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Figure 3: Representative results showedWnt3a promoted proliferation and self-renewal ability of hPDLCs. (a) Wnt3a-treated cells displayed
a significant increase inDNA content compared to untreated cells cultured in proliferationmedium. (b)Wnt3a-treated cells exhibited a higher
expression of Oct4, Nanog, and Sox2 after 5 days of culture. ∗𝑃 < 0.05; error bars represent standard deviation.
were investigated to evaluate whether the functionality of
Wnt3a-pretreated cells was affected by the shorter cell dou-
bling time. The results showed that both Wnt3a-pretreated
cells and control cells showed abilities to proliferate, form
colonies, and osteogenically differentiate. In addition, no
difference was observed between Wnt3a-pretreated cells and
control cells in terms of DNA content (Figure 5(a)), CFU
number (Figure 5(b)), ALP activity (Figure 5(c)), or calcium
content (Figure 5(d)).
4. Discussion
The aim of the current study was to evaluate the effect of
STRO-1 cell sorting and Wnt3a treatment on cell behavior
of hPDLCs. The characteristics of unsorted parental cells
and expanded STRO-1-sorted cells were compared to find
the appropriate PDL cell population for clinical applications.
The effect of Wnt3a on proliferation, self-renewal, and osteo-
genesis of hPDLCs was evaluated to test the potential of
Wnt3a for in vitro expansion of hPDLCs. No differences were
measured between the expanded STRO-1-sorted cells and
unsorted parental cells in terms of proliferation, CFU, and
mineralization capacity. Wnt3a promoted the proliferation
and self-renewal ability of hPDLCs, as displayed by an
increased DNA content, shorter population doubling time,
and higher expression of Oct4. Wnt3a also stimulated the
efficient in vitro expansion of hPDLCs for at least 5 passages
without affecting cell functionalities in terms of proliferation,
CFU, and osteogenic capacity.
STRO-1 positive cells are usually found in low numbers
[13] and therefore in vitro expansion is needed. Our results
showed that the percentage of STRO-1 positive cells decreased
significantly during culture expansion. Additionally, after 4
passages of in vitro expansion, there were no differences
in proliferation, CFU ability, and mineralization capacity
between sorted and initially unsorted cells. A similar phe-
nomenon has been observed with hBMSCs (unpublished
data): the STRO-1 sorted hBMSCs returned to the same state
as their unsorted parental cells only in 7 days of in vitro
expansion. Based on the results and also the time-consuming
procedure of the cell selection and expansion, unsorted
primary cells may provide a better cell source for future
clinical applications. Therefore, unsorted hPDLCs were used
in the current study to test the effect of Wnt3a.
The outcome of DNA content indicates that Wnt3a
enhances the proliferation of hPDLCs significantly. Addition-
ally during the long-term study, the cells were treated with or
withoutWnt3a for 5 passages with the same cell seeding den-
sity. Wnt3a-treated cells showedmore cell doublings than the
control group at each passage, indicating the enhancement of
Wnt3a on the proliferation of hPDLCs.Oct4,Nanog, and Sox2
are key regulators essential for self-renewal of pluripotent
cells [26]. These self-renewal factors are also expressed in
hPDLCs [12, 27] and thus they were chosen in this study.
Based upon the results, the self-renewal ability of hPDLCs
was promoted byWnt3a as displayed by the higher expression
of self-renewal gene expressions. This is consistent with one
previous study in which self-renewal and gene expression
were stimulated in embryonic stem cells by adding Wnt3a
[28]. These results do suggest that Wnt3a may benefit the in
vitro expansion of primary cells for further cell-based clinical
applications.
Our results further suggest that Wnt3a mediates some
aspects of osteogenic differentiation. ALP mRNA-levels and
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Figure 4: Representative results showedWnt3a delayed osteogenic differentiation of hPDLCs. (a) ALP mRNA was downregulated byWnt3a
after 7 days of osteogenic induction. (b) The gene expression was equal for Runx-2 and OC between two groups. (c) ALP activity was
downregulated by Wnt3a on days 7 and 10. (d) Wnt3a has no effect on the calcium content after 30 days of osteogenic induction. ∗𝑃 < 0.05;
error bars represent standard deviation.
ALP-activity were reduced significantly by Wnt3a during
osteogenic differentiation. On the other hand, it has to be
noted that for the mineralization, no effect of Wnt3a was
observed after 30 days of culture, indicating Wnt3a may have
a delayed effect on osteogenic differentiation of hPDLCs.
The effect of Wnt signaling on the STRO-1+ cells in the
efficiency of osteogenic differentiation was not evaluated
here. Since cells selected by mesenchymal stem-cell marker
STRO-1 are considered to be in an undifferentiated state,
it can be speculated that enhanced activation of canonical
Wnt signaling could also inhibit osteogenic differentiation of
STRO-1+ cells based on the previous study, where it has been
demonstrated that enhanced activation of canonical Wnt sig-
naling hindered osteogenic differentiation of undifferentiated
MSCs. Interestingly, some in vivo studies reported thatWnt3a
could enhance implant osseointegration [25] and promote a
better healing of a calvarial defect in adult mice [24]. The
enhancement of proliferation or self-renewal by Wnt3a may
explain the acceleration of osteogenesis in vivo.
RecentlyYamada et al. reported thatXAV939, an inhibitor
of canonical Wnt signaling, inhibited ALP activity of hPDL-
derived MSCs, indicating the promoting effect of canonical
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Figure 5: Representative results showed Wnt3a pretreatment did not affect functionality of hPDLCs after long-term expansion. (a) No
difference inDNAcontentwas observed betweenWnt3a-pretreated cells and control cells after 5 passages. (b)Wnt3a-pretreated cells displayed
no difference compared to the control cells in CFU number. (c) No difference in ALP activity was observed between Wnt3a-pretreated cells
and control cells. (d) No difference in calcium content was detected between Wnt3a-pretreated cells and control cells after 5 passages. Error
bars represent standard deviation.
Wnt signaling pathway during the osteogenic differentiation
of hPDLCs [29]. However, this mechanism is not consistent
with the findings from this and also the other studies [23, 30].
This discrepancy might be caused by the complexity of Wnt
signaling. It has been reported that activation of canonical
Wnt signaling may bring out opposite biological activity in
the context of osteogenic differentiation depending on the
threshold levels of its activation, the status of cell, and Wnt
ligands concentration [24]. Therefore, the comprehensive
understanding of the roles of both appropriate dose con-
centrations of Wnt3a treatment and endogenous activity of
canonical Wnt signaling will be needed in further studies.
More hPDLCs with higher self-renewal ability can be
obtained by using Wnt3a. To further confirm the function-
ality of Wnt3a expanded hPDLCs, we subcultured hPDLCs
from passage 4 with or without Wnt3a up to passage 9
and compared the functionalities of Wnt3a-pretreated and
control cells. Wnt3a promoted the rapid in vitro expansion
of hPDLCs for at least 5 passages, as displayed by the
shorter population doubling time, without interfering with
their functionalities compared to untreated control cells.
Wnt3a pretreatment resulted in much more hPDLCs with
similar proliferation, CFU, and osteogenic capacity as the
untreated control cells, which is of importance for the
clinical use of hPDLCs because a large number of cells
are required for cytotherapeutic purposes. In a previous
study, Zeng and Nusse reported that Wnt3a could promote
long-term expansion of mammary stem cells and main-
tain their self-renewal ability [22]. These data indicate that
Wnt3a may be used as a useful culture supplement for
the in vitro expansion of hPDLCs to benefit their clinical
application.
BioMed Research International 9
5. Conclusions
The proliferation, CFU, and mineralization capacity of
parental hPDLCs and expanded STRO-1-sorted cells were
compared to find the appropriate PDL cell population for
future clinical applications. The results provide evidence that
STRO-1-sorted hPDLCs after expansion are not superior
compared to their unsorted parental cells, suggesting the
time-consuming cell selection and expansion procedure can
be avoided in cell-based periodontal regeneration. In con-
trast,Wnt3a does have an effect on hPDLCs by promoting cell
proliferation and self-renewal, as displayed by an increased
DNA content, a shorter cell population doubling time, and
higher expression of the self-renewal gene Oct4. In addition,
Wnt3a promoted the efficient in vitro expansion of hPDLCs
for at least 5 passages without affecting the self-renewal and
osteogenic differentiation capacity, indicating its potential for
rapid and efficient in vitro cell expansion for future clinical
applications.
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